You have 9 free searches left this month | for more free features.

City

Bethesda (1)

El Segundo (1)

New York (1)

Philadelphia (1)

Condition

Head and Neck Cancer (1)

Head and Neck Neoplasms (1)

Human Immunodeficiency Virus (1)

NonHodgkin's Lymphoma Refractory (1)

Overall Status

Not yet recruiting (2)

Active, not recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 1/phase 2 (1)

Sponsor

ImmunityBio, Inc. (1)

National Cancer Institute (NCI) (1)

Rockefeller University (1)

Collaborator

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Perelman School of Medicine University of Pennsylvania (1)

Weill Medical College of Cornell University (1)

Intervention

n803 (3)

10-1074-ls (1)

3bnc117-ls (1)

cd19t-hank suspension (1)

cyclophosphamide (1)

fludarabine (1)

m7824 (1)

rituximab (1)

triad vaccine (1)

Study Documents

Intervention Type

drug (3)

biological (2)

Funder Type

Industry (1)

NIH (1)

Other (1)

Study Type

Interventional (3)

n803

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Head Neck Cancer, Head and Neck Tumors Trial run by the NCI (M7824, N803, TriAd vaccine)

Active, not recruiting

Head and Neck Cancer
Head and Neck Neoplasms

M7824
+2 more

Bethesda, Maryland

National Institutes of Health Clinical Center

Jan 26, 2023

NonHodgkin's Lymphoma Refractory Trial in El Segundo (N803, CD19t-haNK suspension, Cyclophosphamide)

Not yet recruiting

NonHodgkin's Lymphoma Refractory

N803
+4 more

El Segundo, California

CSSIFM

Nov 9, 2022

Human Immunodeficiency Virus Trial in New York, Philadelphia (3BNC117-LS, 10-1074-LS, N803)

Not yet recruiting

Human Immunodeficiency Virus

3BNC117-LS
+2 more

New York, New York
+2 more

Jul 12, 2022